Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11787833
Modified cyclic dinucleoside compounds as sting modulators
granted -
US 11786548
Trace element compositions, methods of making and use
granted -
US 11787764
Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems
granted -
US 11786603
Optimized transglutaminase site-specific antibody conjugation
granted -
US 11786524
Pharmaceutical compounds
granted -
US 11786635
Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration
granted -
US 11786508
Use of sublingual dexmedetomidine for the treatment of agitation
granted -
US 11787771
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 11787869
Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness
granted -
US 11786602
ASH1L degraders and methods of treatment therewith
granted -
US 11786601
Pegylated capsule-degrading enzyme for the treatment of anthrax
granted -
US 11786598
Lipid formulations for delivery of therapeutic agents
granted -
US 11787800
BRD9 degraders and uses thereof
granted -
US 11786560
Immunoisolation device
granted -
US 11786479
Nucleic acid nanocapsules for drug delivery and targeted gene knockdown
granted -
US 11790574
System and method for carbon dioxide angiographic roadmap imaging
granted -
US 11786486
Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
granted -
US 11787867
Anti-GITR antibodies and uses thereof
granted -
US 11788141
MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
granted -
US 11786554
Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene
granted -
US 11787840
Compositions and methods for treating and preventing autoimmune induced cardiac long QT syndrome
granted -
US 11786503
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 11786502
Method of treatment
granted -
US 11786539
Aminoglycoside derivatives and uses thereof in treating genetic disorders
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.